The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
about
sameAs
The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivoApelin signaling antagonizes Ang II effects in mouse models of atherosclerosisThe Apelin-APJ System in the Evolution of Heart FailureApelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular systemApelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertensionInhibitory effect of apelin-12 on nocturnal food intake in the ratAgonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptorsThe hepatic apelin system: a new therapeutic target for liver diseaseApelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin releaseInteractions between apelin and angiotensin II on rat portal veinElabela-apelin receptor signaling pathway is functional in mammalian systems.In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failurePostnatal overfeeding causes early shifts in gene expression in the heart and long-term alterations in cardiometabolic and oxidative parameters.Apelin is necessary for the maintenance of insulin sensitivity.Gene expression programs of mouse endothelial cells in kidney development and disease.Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells.Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseasesUpregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouseApelin in epiretinal membranes of patients with proliferative diabetic retinopathy.Biased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanineApelin receptor (APJ) expression during cardiopulmonary bypass in children undergoing surgical repair.Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets.Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity.Apelin-13 inhibits large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle cells via a PI3-kinase dependent mechanism.APpEaLINg therapeutic target for obesity cardiomyopathy?The relationship between apelin and cardiac parameters in patients on peritoneal dialysis: is there a new cardiac marker?A story of two ACEs.Reduction of arterial stiffness by exercise training is associated with increasing plasma apelin level in middle-aged and older adultsApelin and insulin resistance: another arrow for the quiver?Apelin serum level in Egyptian patients with chronic hepatitis CGenetic differences and aberrant methylation in the apelin system predict the risk of high-altitude pulmonary edema.Apelin attenuates UVB-induced edema and inflammation by promoting vessel functionRequirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis.Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver CirrhosisSpatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis.Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes.
P2860
Q24643958-2F9FD2E1-49E7-41DD-9F37-24872564A5CEQ24657323-1EB52DA6-8135-4113-A3F6-D3374A3A378DQ26777306-D736FFF1-DF8C-48A8-864C-027F16A2B140Q26823618-417CEEA7-BAD0-4968-902D-399CB6EB5DAEQ27010531-D86BA7E5-A861-4391-92E2-9A21BEA2FC83Q28177602-E599A8E9-4B4A-4993-8803-E5514929B3E7Q28188160-BD89C3A0-BD67-4399-B8A9-8AA8F1DBB3AEQ28295197-401C8BDB-1EA1-4CE3-8500-2A4C68C382FDQ28569332-D5729906-258C-44F1-ADD0-1DCD19575116Q28573763-72801781-0B02-4F38-80D0-C5FE5A45541DQ30032663-FCF14FB4-825B-436D-9908-0A51340DA328Q30484162-68695497-F844-4CC8-89C2-C4074D7CFBCCQ31112217-18AEED62-2C3A-4910-814F-2266785258D1Q33589049-F727E9DA-920D-45A6-AA47-29977C26BFA5Q33656631-1C4F6316-7EA6-48FF-89D6-F8BD0805DA32Q33855590-0E5200D9-E9FD-4D73-9177-A71B57D750B0Q33905732-D17800A6-D781-4F1E-8F2E-2D040BE09E00Q33906868-FD62DB90-A786-45AB-9AB7-431937A24E3EQ33990716-4402C634-6193-4277-97FD-B5FC4C38F561Q34107370-1F82E9FB-CBBA-464C-863C-482A8B475489Q34128580-1092244F-97F0-48DA-BF20-378DDA817B88Q34163846-9DF763E1-6C72-403B-B1BF-AD81329C7FF9Q34507329-35F1D8E7-7DB7-4F35-AC87-0E5A214CC43CQ34677468-368FB478-31EC-4452-84B1-1C73E70C1DACQ34837608-BCB44893-AAE6-4BED-B4B3-1A7678742954Q35046722-DFD00E21-A31B-4D2A-B591-985A2D5D1435Q35080157-F99D4065-3C2D-4385-B054-07D4167749B0Q35082986-321C8B81-51AE-48C5-82E8-A3D5DF0D6738Q35085476-EC3DDB0A-F3B1-42E8-AA6D-9E50F05C72DBQ35109747-50C7D68A-8A3F-4466-9F94-B804E8BBBBB7Q35137602-D1A04645-3EC2-4012-A121-1988D29943B1Q35166911-EEC42549-14E0-4F74-8801-02067BACB887Q35294979-E62F8C38-5C4D-4C92-8066-F96E1229E315Q35616324-0D121532-B78F-450F-BD0C-2221F1081CC8Q35679447-F60E8A95-2232-4D40-BC4F-402D701ECC45Q36095672-9E84B13C-3F5F-40F3-8D3A-2AF7BF0F6767Q36167351-32043529-5E42-4794-B487-1B4FB94D822EQ36412910-55109905-2A6D-4D4C-9ECA-683D8F6D0C1BQ36456603-3FF63FEA-40C1-4EBD-9E90-A1064D077758Q36499842-E35A84BE-6A9A-4BD8-BBAD-ED9F4881442F
P2860
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@ast
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@en
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@nl
type
label
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@ast
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@en
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@nl
prefLabel
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@ast
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@en
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@nl
P2093
P3181
P1433
P1476
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
@en
P2093
K Takayama
K Tatemoto
M Fujimiya
P3181
P356
10.1016/S0167-0115(01)00236-1
P407
P577
2001-06-15T00:00:00Z